tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
RAPP
Rapport Therapeutics, Inc.
RESEARCH TOOLSreports

Rapport Therapeutics, Inc. (RAPP) Stock News & Sentiment

Compare
115 Followers
Premium
Ratings
Promising Outlook for Rapport Therapeutics: Buy Rating Backed by RAP-219’s Clinical Success and Strategic Growth Plans
14d ago
RAPP
Premium
Ratings
Buy Rating for Rapport Therapeutics: Promising Efficacy and Market Potential of RAP-219 in Epilepsy and Bipolar Mania
1M ago
RAPP
Premium
Ratings
Buy Rating for Rapport Therapeutics: Promising RAP-219 Results and Strong Financial Position
1M ago
RAPP
Premium
Company Announcements
Rapport Therapeutics Reports Q3 2025 Financial Results
2M ago
RAPP
Premium
Ratings
Promising Phase II Results and Strong Financial Position Drive Buy Rating for Rapport Therapeutics
2M ago
RAPP
Premium
Company Announcements
Rapport Therapeutics’ New Study on RAP-219: A Potential Game-Changer for Epilepsy Treatment
2M ago
RAPP
Premium
Company Announcements
Rapport Therapeutics’ RAP-219 Study: A Potential Game-Changer for Bipolar I Disorder
2M ago
RAPP
More RAPP News >

RAPP News on the Web

Rapport Therapeutics, Inc. (RAPP) Is Up 9.03% in One Week: What You Should Know
Zacks
Neutral
Rapport Therapeutics, Inc. (RAPP) Has a New Rating from BTIG
TipRanks News
Neutral
Wall Street Analysts See a 74.99% Upside in Rapport Therapeutics, Inc. (RAPP): Can the Stock Really Move This High?
Zacks
Bullish
H.C. Wainwright Keeps Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)
TipRanks News
Neutral
Wall Street Analysts Think Rapport Therapeutics, Inc. (RAPP) Could Surge 104.47%: Read This Before Placing a Bet
Zacks
Bullish
H.C. Wainwright Remains a Buy on Rapport Therapeutics, Inc. (RAPP)
TipRanks News
Neutral
Why Rapport Therapeutics, Inc.’s (RAPP) Stock Is Down 6.64%
AAII
Neutral
Why Rapport Therapeutics, Inc.’s (RAPP) Stock Is Up 5.36%
AAII
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RAPP’s Media Buzz Sentiment?
Currently, no data Available
What is RAPP’s weekly average amount of articles?
Currently, no data Available
What is RAPP’s News Sentiment?
Currently, no data Available
General Stocks that are Trending in the News
UMA-USDUMA
ONDO-USDOndo
UNI-USDUniswap
SEI-USDSei
VET-USDVeChain
Showing the stocks with the most bullish news sentiment over the past week